Cover Image
Market Research Report
Product code
1031930

Head & Neck Cancer Diagnostics Market Research Report by Diagnostic Method, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

Published: | 360iResearch LLP | 181 Pages | Delivery time: 1-2 business days

Price

Back to Top
Head & Neck Cancer Diagnostics Market Research Report by Diagnostic Method, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
Published: October 8, 2021
360iResearch LLP
Content info: 181 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

The Global Head & Neck Cancer Diagnostics Market size was estimated at USD 1,103.83 million in 2020 and expected to reach USD 1,283.21 million in 2021, at a CAGR 16.58% to reach USD 2,772.28 million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Head & Neck Cancer Diagnostics to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Diagnostic Method, the market was studied across Bioscopy Screening, Blood Tests, Dental Diagnostic, Diagnostic Imaging, and Endoscopy Screening.
  • Based on End User, the market was studied across Diagnostic Centers, Hospitals, and Other.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Head & Neck Cancer Diagnostics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Head & Neck Cancer Diagnostics Market, including Addent, Inc., Fujifilm Holdings, GE Healthcare, Hitachi Medical, Identafi, Neusoft, Philips Healthcare, Siemens Healthcare, Toshiba, and Varian Medical Systems.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Head & Neck Cancer Diagnostics Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Head & Neck Cancer Diagnostics Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Head & Neck Cancer Diagnostics Market?
  • 4. What is the competitive strategic window for opportunities in the Global Head & Neck Cancer Diagnostics Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Head & Neck Cancer Diagnostics Market?
  • 6. What is the market share of the leading vendors in the Global Head & Neck Cancer Diagnostics Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Head & Neck Cancer Diagnostics Market?
Table of Contents
Product Code: MRR-437E9896A541

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Define: Research Objective
  • 2.3. Determine: Research Design
  • 2.4. Prepare: Research Instrument
  • 2.5. Collect: Data Source
  • 2.6. Analyze: Data Interpretation
  • 2.7. Formulate: Data Verification
  • 2.8. Publish: Research Report
  • 2.9. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cumulative Impact of COVID-19

5. Market Dynamics

  • 5.1. Introduction
  • 5.2. Drivers
    • 5.2.1. Increasing number of diagnostic procedures for head and neck cancer
    • 5.2.2. Rise in government and private body initiatives for cancer diagnostic
    • 5.2.3. Rising human healthcare expenditure and increasing demand for diagnostic imaging
  • 5.3. Restraints
    • 5.3.1. High cost of the devices and unfavourable reimbursement scenarios
  • 5.4. Opportunities
    • 5.4.1. New advancements and innovations in diagnostic methodology
    • 5.4.2. Large research funding in oncological advancement
  • 5.5. Challenges
    • 5.5.1. Dearth of trained professionals

6. Head & Neck Cancer Diagnostics Market, by Diagnostic Method

  • 6.1. Introduction
  • 6.2. Bioscopy Screening
  • 6.3. Blood Tests
  • 6.4. Dental Diagnostic
  • 6.5. Diagnostic Imaging
  • 6.6. Endoscopy Screening

7. Head & Neck Cancer Diagnostics Market, by End User

  • 7.1. Introduction
  • 7.2. Diagnostic Centers
  • 7.3. Hospitals
  • 7.4. Other

8. Americas Head & Neck Cancer Diagnostics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Head & Neck Cancer Diagnostics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand

10. Europe, Middle East & Africa Head & Neck Cancer Diagnostics Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Key Player
  • 11.4. Competitive Scenario
    • 11.4.1. Merger & Acquisition
    • 11.4.2. Agreement, Collaboration, & Partnership
    • 11.4.3. New Product Launch & Enhancement
    • 11.4.4. Investment & Funding
    • 11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Addent, Inc.
  • 12.2. Fujifilm Holdings
  • 12.3. GE Healthcare
  • 12.4. Hitachi Medical
  • 12.5. Identafi
  • 12.6. Neusoft
  • 12.7. Philips Healthcare
  • 12.8. Siemens Healthcare
  • 12.9. Toshiba
  • 12.10. Varian Medical Systems

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 3. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET: MARKET DYNAMICS
  • FIGURE 4. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2020 VS 2026 (%)
  • FIGURE 5. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2020 VS 2026 (USD MILLION)
  • FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2026
  • FIGURE 7. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY BIOSCOPY SCREENING, 2018-2026 (USD MILLION)
  • FIGURE 8. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY BIOSCOPY SCREENING, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 9. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2026 (USD MILLION)
  • FIGURE 10. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 11. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DENTAL DIAGNOSTIC, 2018-2026 (USD MILLION)
  • FIGURE 12. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DENTAL DIAGNOSTIC, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 13. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2026 (USD MILLION)
  • FIGURE 14. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 15. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY ENDOSCOPY SCREENING, 2018-2026 (USD MILLION)
  • FIGURE 16. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY ENDOSCOPY SCREENING, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 17. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2020 VS 2026 (%)
  • FIGURE 18. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
  • FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2026
  • FIGURE 20. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2026 (USD MILLION)
  • FIGURE 21. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 22. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2026 (USD MILLION)
  • FIGURE 23. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 24. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY OTHER, 2018-2026 (USD MILLION)
  • FIGURE 25. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY OTHER, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 26. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 27. ARGENTINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 28. BRAZIL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 29. CANADA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 30. MEXICO HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 31. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 32. ASIA-PACIFIC HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 33. AUSTRALIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 34. CHINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 35. INDIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 36. INDONESIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 37. JAPAN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 38. MALAYSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 39. PHILIPPINES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 40. SINGAPORE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 41. SOUTH KOREA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 42. TAIWAN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 43. THAILAND HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 44. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 45. FRANCE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 46. GERMANY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 47. ITALY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 48. NETHERLANDS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 49. QATAR HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 50. RUSSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 51. SAUDI ARABIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 52. SOUTH AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 53. SPAIN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 54. UNITED ARAB EMIRATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 55. UNITED KINGDOM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 56. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX
  • FIGURE 57. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET: SHARE, BY KEY PLAYER, 2020
  • FIGURE 58. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 4. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2026 (USD MILLION)
  • TABLE 5. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY BIOSCOPY SCREENING, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 6. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 7. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DENTAL DIAGNOSTIC, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 8. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 9. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY ENDOSCOPY SCREENING, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 10. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
  • TABLE 11. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 12. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 13. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY OTHER, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 14. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 15. ARGENTINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 16. BRAZIL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 17. CANADA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 18. MEXICO HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 19. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 20. ASIA-PACIFIC HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 21. AUSTRALIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 22. CHINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 23. INDIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 24. INDONESIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 25. JAPAN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 26. MALAYSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 27. PHILIPPINES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 28. SINGAPORE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 29. SOUTH KOREA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 30. TAIWAN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 31. THAILAND HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 32. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 33. FRANCE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 34. GERMANY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 35. ITALY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 36. NETHERLANDS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 37. QATAR HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 38. RUSSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 39. SAUDI ARABIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 40. SOUTH AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 41. SPAIN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 42. UNITED ARAB EMIRATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 43. UNITED KINGDOM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 44. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET: SCORES
  • TABLE 45. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET: BUSINESS STRATEGY
  • TABLE 46. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET: PRODUCT SATISFACTION
  • TABLE 47. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET: RANKING
  • TABLE 48. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET: SHARE, BY KEY PLAYER, 2020
  • TABLE 49. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET: MERGER & ACQUISITION
  • TABLE 50. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 51. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 52. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET: INVESTMENT & FUNDING
  • TABLE 53. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 54. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET: LICENSE & PRICING